Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Alkermes Plc (NASDAQ:ALKS)

70.02
Delayed Data
As of Jul 31
 +2.49 / +3.69%
Today’s Change
38.49
Today|||52-Week Range
75.17
+19.57%
Year-to-Date

Today’s Trading

Previous close67.53
Today’s open68.52
Day’s range67.76 - 70.71
Volume749,107
Average volume (3 months)992,155
Market cap$10.5B
Dividend yield--
Data as of 3:59pm ET, 07/31/2015

Growth & Valuation

Earnings growth (last year)-229.95%
Earnings growth (this year)-232.90%
Earnings growth (next 5 years)+48.30%
Revenue growth (last year)+7.20%
P/E ratioNM
Price/Sales13.75
Price/Book7.40

Competitors

 Today’s
change
Today’s
% change
RDYDr.Reddy's Laborator...+2.35+3.79%
JAZZJazz Pharmaceuticals...+1.86+0.98%
MDVNMedivation Inc+8.36+8.62%
UTHRUnited Therapeutics ...+6.57+4.04%
Data as of 4:14pm ET, 07/31/2015

Financials

Next reporting dateOctober 28, 2015
EPS forecast (this quarter)-$0.20
Annual revenue (last year)$618.8M
Annual profit (last year)-$30.1M
Net profit margin-4.86%

Profile

Sector
Health Technology
Industry
Biotechnology
Chairman &
Chief Executive Officer
Richard F. Pops
President
Shane M. Cooke
Corporate headquarters
Dublin, Dublin

Forecasts